BeOne Medicines (ONC) Net Margin Growth (3y) (2018 - 2026)

BeOne Medicines (ONC) Net Margin Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 9,283.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -569.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 4,144.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 7,218.00

Historic Data

Download Data
DateValue
Mar 31, 2026 9,283.00
Dec 31, 2025 12,160.00
Sep 30, 2025 15,268.00
Jun 30, 2025 17,280.00
Mar 31, 2025 14,204.00
Dec 31, 2024 26,258.00
Sep 30, 2024 20,011.00
Jun 30, 2024 30,729.00
Mar 31, 2024 -4,439.00
Dec 31, 2023 44,228.00
Sep 30, 2023 49,597.00
Jun 30, 2023 44,838.00
Mar 31, 2023 62,320.00
Dec 31, 2022 56,465.00
Sep 30, 2022 47,175.00
Jun 30, 2022 -13,030.00
Mar 31, 2022 7,400.00
Dec 31, 2021 17,855.00
Sep 30, 2021 5,436.00
Jun 30, 2021 -2,313.00